PRESIDIO MANAGEMENT GROUP VIII L L C
Insider CIK 1225484 · MXL 10% owner · OMED 10% owner · ATRC 10% owner · GWRE 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| OMED OncoMed Pharmaceuticals In | J Other | 2014-08-08 | 2014-08-12 | 33,089 | — | $0 | 50,471 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | J Other | 2014-08-08 | 2014-08-12 | 8,863 | — | $0 | 18,170 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | J Other | 2014-08-08 | 2014-08-12 | 27,573 | — | $0 | 27,573 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | J Other | 2014-08-08 | 2014-08-12 | 27,572 | — | $0 | 56,528 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | J Other | 2014-08-08 | 2014-08-12 | 937,205 | — | $0 | 1,990,783 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | J Other | 2014-08-08 | 2014-08-12 | 9,046 | — | $0 | 19,215 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | J Other | 2014-08-08 | 2014-08-12 | 285,734 | — | $0 | 285,734 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | J Other | 2014-08-08 | 2014-08-12 | 285,734 | — | $0 | 0 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | J Other | 2014-08-08 | 2014-08-12 | 27,573 | — | $0 | 27,573 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | S Sale | 2014-06-10 | 2014-06-11 | 3,186 | $24.48 | $78.0K | 21,944 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | S Sale | 2014-06-10 | 2014-06-11 | 1,614 | $24.48 | $39.5K | 11,123 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | S Sale | 2014-06-09 | 2014-06-11 | 2,776 | $24.62 | $68.3K | 15,513 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | S Sale | 2014-06-09 | 2014-06-11 | 5,476 | $24.62 | $134.8K | 30,606 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | S Sale | 2014-05-15 | 2014-05-19 | 28,956 | $22.51 | $651.8K | 0 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | S Sale | 2014-05-12 | 2014-05-13 | 28,956 | $21.99 | $636.7K | 0 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | S Sale | 2014-05-12 | 2014-05-13 | 17,371 | $21.98 | $381.8K | 17,382 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | J Other | 2014-05-09 | 2014-05-13 | 34,743 | — | $0 | 34,743 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | J Other | 2014-05-09 | 2014-05-13 | 9,307 | — | $0 | 9,307 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | J Other | 2014-05-09 | 2014-05-13 | 28,956 | — | $0 | 28,956 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | J Other | 2014-05-09 | 2014-05-13 | 28,956 | — | $0 | 28,956 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | J Other | 2014-05-09 | 2014-05-13 | 28,966 | — | $0 | 28,966 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | J Other | 2014-05-09 | 2014-05-13 | 300,063 | — | $0 | 0 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | J Other | 2014-05-09 | 2014-05-13 | 300,063 | — | $0 | 300,063 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | J Other | 2014-05-09 | 2014-05-13 | 9,421 | — | $0 | 28,261 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | J Other | 2014-05-09 | 2014-05-13 | 975,996 | — | $0 | 2,927,988 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | C Conversion deriv | 2013-07-23 | 2013-07-23 | 9,926 | — | $0 | 0 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | C Conversion deriv | 2013-07-23 | 2013-07-23 | 4,817 | — | $0 | 0 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | C Conversion deriv | 2013-07-23 | 2013-07-23 | 1,215,407 | — | $0 | 0 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | C Conversion deriv | 2013-07-23 | 2013-07-23 | 11,233 | — | $0 | 0 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | C Conversion deriv | 2013-07-23 | 2013-07-23 | 5,694 | — | $0 | 0 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | C Conversion deriv | 2013-07-23 | 2013-07-23 | 11,731 | — | $0 | 0 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | C Conversion deriv | 2013-07-23 | 2013-07-23 | 1,505,032 | — | $0 | 0 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | C Conversion deriv | 2013-07-23 | 2013-07-23 | 13,910 | — | $0 | 0 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | C Conversion deriv | 2013-07-23 | 2013-07-23 | 7,051 | — | $0 | 0 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | C Conversion deriv | 2013-07-23 | 2013-07-23 | 14,527 | — | $0 | 0 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | C Conversion deriv | 2013-07-23 | 2013-07-23 | 1,028,381 | — | $0 | 0 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | C Conversion deriv | 2013-07-23 | 2013-07-23 | 9,505 | — | $0 | 0 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | C Conversion deriv | 2013-07-23 | 2013-07-23 | 11,233 | — | $0 | 0 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | C Conversion deriv | 2013-07-23 | 2013-07-23 | 1,028,381 | — | $0 | 0 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | C Conversion deriv | 2013-07-23 | 2013-07-23 | 9,505 | — | $0 | 0 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | C Conversion deriv | 2013-07-23 | 2013-07-23 | 4,817 | — | $0 | 0 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | C Conversion deriv | 2013-07-23 | 2013-07-23 | 9,926 | — | $0 | 0 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | C Conversion deriv | 2013-07-23 | 2013-07-23 | 1,215,407 | — | $0 | 0 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | C Conversion deriv | 2013-07-23 | 2013-07-23 | 14,527 | — | $0 | 0 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | C Conversion deriv | 2013-07-23 | 2013-07-23 | 5,694 | — | $0 | 0 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | C Conversion deriv | 2013-07-23 | 2013-07-23 | 11,731 | — | $0 | 0 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | C Conversion deriv | 2013-07-23 | 2013-07-23 | 1,505,032 | — | $0 | 0 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | C Conversion deriv | 2013-07-23 | 2013-07-23 | 13,910 | — | $0 | 0 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | C Conversion deriv | 2013-07-23 | 2013-07-23 | 7,051 | — | $0 | 0 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | C Conversion | 2013-07-23 | 2013-07-23 | 14,527 | — | $0 | 36,184 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | C Conversion | 2013-07-23 | 2013-07-23 | 1,215,407 | — | $0 | 2,243,788 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | C Conversion | 2013-07-23 | 2013-07-23 | 1,505,032 | — | $0 | 3,748,820 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | P Buy | 2013-07-23 | 2013-07-23 | 155,164 | $17.00 | $2.64M | 3,903,984 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | C Conversion | 2013-07-23 | 2013-07-23 | 9,505 | — | $0 | 9,505 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | C Conversion | 2013-07-23 | 2013-07-23 | 11,233 | — | $0 | 20,738 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | C Conversion | 2013-07-23 | 2013-07-23 | 13,910 | — | $0 | 34,648 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | P Buy | 2013-07-23 | 2013-07-23 | 1,434 | $17.00 | $24.4K | 36,082 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | C Conversion | 2013-07-23 | 2013-07-23 | 4,817 | — | $0 | 4,817 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | C Conversion | 2013-07-23 | 2013-07-23 | 5,694 | — | $0 | 10,511 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | C Conversion | 2013-07-23 | 2013-07-23 | 7,051 | — | $0 | 17,562 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | P Buy | 2013-07-23 | 2013-07-23 | 727 | $17.00 | $12.4K | 18,289 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | C Conversion | 2013-07-23 | 2013-07-23 | 9,926 | — | $0 | 9,926 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | C Conversion | 2013-07-23 | 2013-07-23 | 11,731 | — | $0 | 21,657 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | P Buy | 2013-07-23 | 2013-07-23 | 1,498 | $17.00 | $25.5K | 37,682 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | C Conversion | 2013-07-23 | 2013-07-23 | 1,028,381 | — | $0 | 1,028,381 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | P Buy | 2013-07-23 | 2013-07-23 | 1,434 | $17.00 | $24.4K | 36,082 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | C Conversion | 2013-07-23 | 2013-07-23 | 4,817 | — | $0 | 4,817 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | C Conversion | 2013-07-23 | 2013-07-23 | 5,694 | — | $0 | 10,511 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | C Conversion | 2013-07-23 | 2013-07-23 | 7,051 | — | $0 | 17,562 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | P Buy | 2013-07-23 | 2013-07-23 | 727 | $17.00 | $12.4K | 18,289 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | C Conversion | 2013-07-23 | 2013-07-23 | 9,926 | — | $0 | 9,926 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | C Conversion | 2013-07-23 | 2013-07-23 | 11,731 | — | $0 | 21,657 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | C Conversion | 2013-07-23 | 2013-07-23 | 14,527 | — | $0 | 36,184 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | P Buy | 2013-07-23 | 2013-07-23 | 1,498 | $17.00 | $25.5K | 37,682 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | C Conversion | 2013-07-23 | 2013-07-23 | 1,028,381 | — | $0 | 1,028,381 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | C Conversion | 2013-07-23 | 2013-07-23 | 1,215,407 | — | $0 | 2,243,788 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | C Conversion | 2013-07-23 | 2013-07-23 | 1,505,032 | — | $0 | 3,748,820 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | P Buy | 2013-07-23 | 2013-07-23 | 155,164 | $17.00 | $2.64M | 3,903,984 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | C Conversion | 2013-07-23 | 2013-07-23 | 9,505 | — | $0 | 9,505 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | C Conversion | 2013-07-23 | 2013-07-23 | 13,910 | — | $0 | 34,648 | SEC↗ |
| OMED OncoMed Pharmaceuticals In | C Conversion | 2013-07-23 | 2013-07-23 | 11,233 | — | $0 | 20,738 | SEC↗ |
| GWRE Guidewire Software, Inc. | J Other | 2012-09-25 | 2012-09-25 | 14,737 | — | $0 | 36,638 | SEC↗ |
| GWRE Guidewire Software, Inc. | J Other | 2012-09-25 | 2012-09-25 | 2,000,000 | — | $0 | 4,972,862 | SEC↗ |
| GWRE Guidewire Software, Inc. | J Other | 2012-09-25 | 2012-09-25 | 14,737 | — | $0 | 36,638 | SEC↗ |
| GWRE Guidewire Software, Inc. | J Other | 2012-09-25 | 2012-09-25 | 2,000,000 | — | $0 | 4,972,862 | SEC↗ |
| GWRE Guidewire Software, Inc. | S Sale | 2012-09-18 | 2012-09-18 | 3,111 | $31.13 | $96.8K | 65,325 | SEC↗ |
| GWRE Guidewire Software, Inc. | S Sale | 2012-09-18 | 2012-09-18 | 1,669 | $31.13 | $52.0K | 35,047 | SEC↗ |
| GWRE Guidewire Software, Inc. | S Sale | 2012-09-18 | 2012-09-18 | 1,669 | $31.13 | $52.0K | 35,047 | SEC↗ |
| GWRE Guidewire Software, Inc. | S Sale | 2012-09-18 | 2012-09-18 | 3,111 | $31.13 | $96.8K | 65,325 | SEC↗ |
| GWRE Guidewire Software, Inc. | S Sale | 2012-09-17 | 2012-09-18 | 7,127 | $31.30 | $223.1K | 36,716 | SEC↗ |
| GWRE Guidewire Software, Inc. | S Sale | 2012-09-17 | 2012-09-18 | 13,284 | $31.30 | $415.8K | 68,436 | SEC↗ |
| GWRE Guidewire Software, Inc. | S Sale | 2012-09-17 | 2012-09-18 | 13,284 | $31.30 | $415.8K | 68,436 | SEC↗ |
| GWRE Guidewire Software, Inc. | S Sale | 2012-09-17 | 2012-09-18 | 7,127 | $31.30 | $223.1K | 36,716 | SEC↗ |
| GWRE Guidewire Software, Inc. | J Other | 2012-09-10 | 2012-09-12 | 12,895 | — | $0 | 51,375 | SEC↗ |
| GWRE Guidewire Software, Inc. | J Other | 2012-09-10 | 2012-09-12 | 1,750,000 | — | $0 | 6,972,862 | SEC↗ |
| GWRE Guidewire Software, Inc. | J Other | 2012-09-10 | 2012-09-12 | 1,750,000 | — | $0 | 6,972,862 | SEC↗ |
| GWRE Guidewire Software, Inc. | J Other | 2012-09-10 | 2012-09-12 | 12,895 | — | $0 | 51,375 | SEC↗ |
| MXL MAXLINEAR INC | S Sale deriv | 2012-08-21 | 2012-08-22 | 488,481 | $5.59 | $2.73M | 2,341,364 | SEC↗ |
| MXL MAXLINEAR INC | S Sale deriv | 2012-08-21 | 2012-08-22 | 4,515 | $5.59 | $25.2K | 21,639 | SEC↗ |
| MXL MAXLINEAR INC | S Sale deriv | 2012-08-21 | 2012-08-22 | 2,289 | $5.59 | $12.8K | 10,969 | SEC↗ |
| MXL MAXLINEAR INC | S Sale deriv | 2012-08-21 | 2012-08-22 | 4,715 | $5.59 | $26.4K | 22,599 | SEC↗ |
| MXL MAXLINEAR INC | S Sale deriv | 2012-08-21 | 2012-08-22 | 2,289 | $5.59 | $12.8K | 10,969 | SEC↗ |
| MXL MAXLINEAR INC | S Sale deriv | 2012-08-21 | 2012-08-22 | 4,715 | $5.59 | $26.4K | 22,599 | SEC↗ |
| MXL MAXLINEAR INC | S Sale deriv | 2012-08-21 | 2012-08-22 | 488,481 | $5.59 | $2.73M | 2,341,364 | SEC↗ |
| MXL MAXLINEAR INC | S Sale deriv | 2012-08-21 | 2012-08-22 | 4,515 | $5.59 | $25.2K | 21,639 | SEC↗ |
| ATRC AtriCure, Inc. | J Other | 2012-06-13 | 2012-06-14 | 350,000 | — | $0 | 1,502,444 | SEC↗ |
| ATRC AtriCure, Inc. | J Other | 2012-06-13 | 2012-06-14 | 2,579 | — | $0 | 11,873 | SEC↗ |
| ATRC AtriCure, Inc. | J Other | 2012-06-13 | 2012-06-14 | 350,000 | — | $0 | 1,502,444 | SEC↗ |
| ATRC AtriCure, Inc. | J Other | 2012-06-13 | 2012-06-14 | 2,579 | — | $0 | 11,873 | SEC↗ |
| ATRC AtriCure, Inc. | S Sale | 2012-06-07 | 2012-06-07 | 3,279 | $9.44 | $31.0K | 18,374 | SEC↗ |
| ATRC AtriCure, Inc. | S Sale | 2012-06-07 | 2012-06-07 | 1,759 | $9.44 | $16.6K | 9,858 | SEC↗ |
| ATRC AtriCure, Inc. | S Sale | 2012-06-07 | 2012-06-07 | 1,759 | $9.44 | $16.6K | 9,858 | SEC↗ |
| ATRC AtriCure, Inc. | S Sale | 2012-06-07 | 2012-06-07 | 3,279 | $9.44 | $31.0K | 18,374 | SEC↗ |
| ATRC AtriCure, Inc. | J Other | 2012-06-06 | 2012-06-07 | 2,579 | — | $0 | 14,452 | SEC↗ |
| ATRC AtriCure, Inc. | J Other | 2012-06-06 | 2012-06-07 | 350,000 | — | $0 | 1,852,444 | SEC↗ |
| ATRC AtriCure, Inc. | J Other | 2012-06-06 | 2012-06-07 | 2,579 | — | $0 | 14,452 | SEC↗ |
| ATRC AtriCure, Inc. | J Other | 2012-06-06 | 2012-06-07 | 350,000 | — | $0 | 1,852,444 | SEC↗ |
| MXL MAXLINEAR INC | S Sale | 2012-05-30 | 2012-05-31 | 1,640 | $4.20 | $6.9K | 0 | SEC↗ |
| MXL MAXLINEAR INC | S Sale | 2012-05-30 | 2012-05-31 | 3,235 | $4.20 | $13.6K | 0 | SEC↗ |
| MXL MAXLINEAR INC | S Sale | 2012-05-30 | 2012-05-31 | 1,640 | $4.20 | $6.9K | 0 | SEC↗ |
| MXL MAXLINEAR INC | S Sale | 2012-05-30 | 2012-05-31 | 3,235 | $4.20 | $13.6K | 0 | SEC↗ |
| MXL MAXLINEAR INC | C Conversion deriv | 2012-05-15 | 2012-05-17 | 3,378 | — | $0 | 27,314 | SEC↗ |
| MXL MAXLINEAR INC | C Conversion deriv | 2012-05-15 | 2012-05-17 | 3,235 | — | $0 | 26,154 | SEC↗ |
| MXL MAXLINEAR INC | C Conversion deriv | 2012-05-15 | 2012-05-17 | 1,640 | — | $0 | 13,258 | SEC↗ |
| MXL MAXLINEAR INC | C Conversion deriv | 2012-05-15 | 2012-05-17 | 350,000 | — | $0 | 2,829,845 | SEC↗ |
| MXL MAXLINEAR INC | C Conversion deriv | 2012-05-15 | 2012-05-17 | 1,640 | — | $0 | 13,258 | SEC↗ |
| MXL MAXLINEAR INC | C Conversion deriv | 2012-05-15 | 2012-05-17 | 350,000 | — | $0 | 2,829,845 | SEC↗ |
| MXL MAXLINEAR INC | C Conversion deriv | 2012-05-15 | 2012-05-17 | 3,378 | — | $0 | 27,314 | SEC↗ |
| MXL MAXLINEAR INC | C Conversion deriv | 2012-05-15 | 2012-05-17 | 3,235 | — | $0 | 26,154 | SEC↗ |
| MXL MAXLINEAR INC | J Other | 2012-05-15 | 2012-05-17 | 3,378 | — | $0 | 0 | SEC↗ |
| MXL MAXLINEAR INC | J Other | 2012-05-15 | 2012-05-17 | 350,000 | — | $0 | 0 | SEC↗ |
| MXL MAXLINEAR INC | C Conversion | 2012-05-15 | 2012-05-17 | 1,640 | — | $0 | 1,640 | SEC↗ |
| MXL MAXLINEAR INC | C Conversion | 2012-05-15 | 2012-05-17 | 3,235 | — | $0 | 3,235 | SEC↗ |
| MXL MAXLINEAR INC | C Conversion | 2012-05-15 | 2012-05-17 | 3,378 | — | $0 | 3,378 | SEC↗ |
| MXL MAXLINEAR INC | C Conversion | 2012-05-15 | 2012-05-17 | 350,000 | — | $0 | 350,000 | SEC↗ |
| MXL MAXLINEAR INC | J Other | 2012-05-15 | 2012-05-17 | 350,000 | — | $0 | 0 | SEC↗ |
| MXL MAXLINEAR INC | C Conversion | 2012-05-15 | 2012-05-17 | 350,000 | — | $0 | 350,000 | SEC↗ |
| MXL MAXLINEAR INC | C Conversion | 2012-05-15 | 2012-05-17 | 3,378 | — | $0 | 3,378 | SEC↗ |
| MXL MAXLINEAR INC | C Conversion | 2012-05-15 | 2012-05-17 | 3,235 | — | $0 | 3,235 | SEC↗ |
| MXL MAXLINEAR INC | J Other | 2012-05-15 | 2012-05-17 | 3,378 | — | $0 | 0 | SEC↗ |
| MXL MAXLINEAR INC | C Conversion | 2012-05-15 | 2012-05-17 | 1,640 | — | $0 | 1,640 | SEC↗ |
| GWRE Guidewire Software, Inc. | S Sale | 2012-04-24 | 2012-04-25 | 15,860 | $28.25 | $448.0K | 43,843 | SEC↗ |
| GWRE Guidewire Software, Inc. | S Sale | 2012-04-24 | 2012-04-25 | 23,250 | $28.25 | $656.8K | 64,270 | SEC↗ |
| GWRE Guidewire Software, Inc. | S Sale | 2012-04-24 | 2012-04-25 | 3,155,311 | $28.25 | $89.14M | 8,722,862 | SEC↗ |
| GWRE Guidewire Software, Inc. | S Sale | 2012-04-24 | 2012-04-25 | 29,561 | $28.25 | $835.1K | 81,720 | SEC↗ |
| GWRE Guidewire Software, Inc. | S Sale | 2012-04-24 | 2012-04-25 | 23,250 | $28.25 | $656.8K | 64,270 | SEC↗ |
| GWRE Guidewire Software, Inc. | S Sale | 2012-04-24 | 2012-04-25 | 29,561 | $28.25 | $835.1K | 81,720 | SEC↗ |
| GWRE Guidewire Software, Inc. | S Sale | 2012-04-24 | 2012-04-25 | 15,860 | $28.25 | $448.0K | 43,843 | SEC↗ |
| GWRE Guidewire Software, Inc. | S Sale | 2012-04-24 | 2012-04-25 | 3,155,311 | $28.25 | $89.14M | 8,722,862 | SEC↗ |
| GWRE Guidewire Software, Inc. | C Conversion deriv | 2012-01-30 | 2012-01-30 | 43,981 | — | $0 | 0 | SEC↗ |
| GWRE Guidewire Software, Inc. | C Conversion deriv | 2012-01-30 | 2012-01-30 | 81,976 | — | $0 | 0 | SEC↗ |
| GWRE Guidewire Software, Inc. | C Conversion deriv | 2012-01-30 | 2012-01-30 | 64,475 | — | $0 | 0 | SEC↗ |
| GWRE Guidewire Software, Inc. | C Conversion deriv | 2012-01-30 | 2012-01-30 | 8,750,236 | — | $0 | 0 | SEC↗ |
| GWRE Guidewire Software, Inc. | C Conversion deriv | 2012-01-30 | 2012-01-30 | 1,882,117 | — | $0 | 0 | SEC↗ |
| GWRE Guidewire Software, Inc. | C Conversion deriv | 2012-01-30 | 2012-01-30 | 13,868 | — | $0 | 0 | SEC↗ |
| GWRE Guidewire Software, Inc. | C Conversion deriv | 2012-01-30 | 2012-01-30 | 17,632 | — | $0 | 0 | SEC↗ |
| GWRE Guidewire Software, Inc. | C Conversion deriv | 2012-01-30 | 2012-01-30 | 9,460 | — | $0 | 0 | SEC↗ |
| GWRE Guidewire Software, Inc. | C Conversion deriv | 2012-01-30 | 2012-01-30 | 972,110 | — | $0 | 0 | SEC↗ |
| GWRE Guidewire Software, Inc. | C Conversion deriv | 2012-01-30 | 2012-01-30 | 7,163 | — | $0 | 0 | SEC↗ |
| GWRE Guidewire Software, Inc. | C Conversion deriv | 2012-01-30 | 2012-01-30 | 9,107 | — | $0 | 0 | SEC↗ |
| GWRE Guidewire Software, Inc. | C Conversion deriv | 2012-01-30 | 2012-01-30 | 4,886 | — | $0 | 0 | SEC↗ |
| GWRE Guidewire Software, Inc. | C Conversion deriv | 2012-01-30 | 2012-01-30 | 1,882,117 | — | $0 | 0 | SEC↗ |
| GWRE Guidewire Software, Inc. | C Conversion deriv | 2012-01-30 | 2012-01-30 | 7,163 | — | $0 | 0 | SEC↗ |
| GWRE Guidewire Software, Inc. | C Conversion deriv | 2012-01-30 | 2012-01-30 | 972,110 | — | $0 | 0 | SEC↗ |
| GWRE Guidewire Software, Inc. | C Conversion deriv | 2012-01-30 | 2012-01-30 | 9,460 | — | $0 | 0 | SEC↗ |
| GWRE Guidewire Software, Inc. | C Conversion deriv | 2012-01-30 | 2012-01-30 | 17,632 | — | $0 | 0 | SEC↗ |
| GWRE Guidewire Software, Inc. | C Conversion deriv | 2012-01-30 | 2012-01-30 | 13,868 | — | $0 | 0 | SEC↗ |
| GWRE Guidewire Software, Inc. | C Conversion deriv | 2012-01-30 | 2012-01-30 | 9,107 | — | $0 | 0 | SEC↗ |
| GWRE Guidewire Software, Inc. | C Conversion deriv | 2012-01-30 | 2012-01-30 | 43,981 | — | $0 | 0 | SEC↗ |
| GWRE Guidewire Software, Inc. | C Conversion deriv | 2012-01-30 | 2012-01-30 | 81,976 | — | $0 | 0 | SEC↗ |
| GWRE Guidewire Software, Inc. | C Conversion deriv | 2012-01-30 | 2012-01-30 | 64,475 | — | $0 | 0 | SEC↗ |
| GWRE Guidewire Software, Inc. | C Conversion deriv | 2012-01-30 | 2012-01-30 | 8,750,236 | — | $0 | 0 | SEC↗ |
| GWRE Guidewire Software, Inc. | C Conversion deriv | 2012-01-30 | 2012-01-30 | 4,886 | — | $0 | 0 | SEC↗ |
| GWRE Guidewire Software, Inc. | C Conversion | 2012-01-30 | 2012-01-30 | 58,327 | — | $0 | 59,703 | SEC↗ |
| GWRE Guidewire Software, Inc. | C Conversion | 2012-01-30 | 2012-01-30 | 11,604,463 | — | $0 | 11,878,173 | SEC↗ |
| GWRE Guidewire Software, Inc. | C Conversion | 2012-01-30 | 2012-01-30 | 85,506 | — | $0 | 87,520 | SEC↗ |
| GWRE Guidewire Software, Inc. | C Conversion | 2012-01-30 | 2012-01-30 | 108,715 | — | $0 | 111,281 | SEC↗ |
| GWRE Guidewire Software, Inc. | C Conversion | 2012-01-30 | 2012-01-30 | 58,327 | — | $0 | 59,703 | SEC↗ |
| GWRE Guidewire Software, Inc. | C Conversion | 2012-01-30 | 2012-01-30 | 11,604,463 | — | $0 | 11,878,173 | SEC↗ |
| GWRE Guidewire Software, Inc. | C Conversion | 2012-01-30 | 2012-01-30 | 85,506 | — | $0 | 87,520 | SEC↗ |
| GWRE Guidewire Software, Inc. | C Conversion | 2012-01-30 | 2012-01-30 | 108,715 | — | $0 | 111,281 | SEC↗ |